For example, SPARC-treated non-small-cell lung cancer cells CL1-5 and H1299 migrate more rapidly [46], and hevin, the closest SPARC family member, has exactly the opposite mode of action, since migration is enhanced in hevin-null primary dermal fibroblasts [47]. This evidence concerns the gene SPARCL1 and non-small cell lung carcinoma.